FMP

FMP

Enter

NUTX - Nutex Health, Inc.

photo-url-https://images.financialmodelingprep.com/symbol/NUTX.png

Nutex Health, Inc.

NUTX

NASDAQ

Nutex Health, Inc. operates as a technology-enabled healthcare services company. It operates through two divisions: Hospital division and Population Health Management division. The Hospital division implements and operates health care models, including micro-hospitals, specialty hospitals, and hospital outpatient departments. This division owns and operates 21 facilities in 8 states. The Population Health Management division owns and operates provider networks, such as independent physician associations. Its management services organizations provide management, administrative, and other support services to its affiliated hospitals and physician groups. This division's cloud-based proprietary technology platform aggregates data across multiple information systems, settings, and sources to create a holistic view of each patient and provider, as well as allows to deliver care. The company is based in Houston, Texas.

114.63 USD

-3.36 (-2.93%)

Operating Data

Year

2020

2021

2022

2023

2024

2025

2026

2027

2028

2029

Revenue

273.42M

331.53M

219.29M

247.65M

479.95M

592.89M

732.42M

904.78M

1.12B

1.38B

Revenue %

-

21.25

-33.85

12.93

93.8

23.53

23.53

23.53

23.53

Ebitda

-5.12M

183.45M

-393.96M

-14.58M

148.65M

-25.44M

-31.43M

-38.82M

-47.96M

-59.24M

Ebitda %

-1.87

55.33

-179.65

-5.89

30.97

-4.29

-4.29

-4.29

-4.29

Ebit

-5.35M

175.69M

-407.16M

-32.17M

129.68M

-41.43M

-51.18M

-63.22M

-78.1M

-96.48M

Ebit %

-1.96

52.99

-185.67

-12.99

27.02

-6.99

-6.99

-6.99

-6.99

Depreciation

236.55k

7.76M

13.2M

17.59M

18.97M

23.12M

28.57M

35.29M

43.59M

53.85M

Depreciation %

0.09

2.34

6.02

7.1

3.95

3.9

3.9

3.9

3.9

Balance Sheet

Year

2020

2021

2022

2023

2024

2025

2026

2027

2028

2029

Total Cash

25.51M

36.12M

34.26M

22M

43.58M

63.81M

78.82M

97.37M

120.29M

148.6M

Total Cash %

9.33

10.89

15.62

8.88

9.08

10.76

10.76

10.76

10.76

Receivables

108.14M

114.76M

58.32M

62.78M

236.05M

207.86M

256.77M

317.19M

391.84M

484.05M

Receivables %

39.55

34.61

26.59

25.35

49.18

35.06

35.06

35.06

35.06

Inventories

1.73M

2.81M

3.53M

3.39M

2.85M

5.99M

7.4M

9.15M

11.3M

13.96M

Inventories %

0.63

0.85

1.61

1.37

0.59

1.01

1.01

1.01

1.01

Payable

8.63M

17.65M

23.93M

25.28M

13.96M

38.55M

47.62M

58.83M

72.67M

89.78M

Payable %

3.16

5.32

10.91

10.21

2.91

6.5

6.5

6.5

6.5

Cap Ex

-61.19M

-36.93M

-14.63M

-9.5M

-2.3M

-52.77M

-65.19M

-80.54M

-99.49M

-122.9M

Cap Ex %

-22.38

-11.14

-6.67

-3.83

-0.48

-8.9

-8.9

-8.9

-8.9

Weighted Average Cost Of Capital

Price

114.63

Beta

Diluted Shares Outstanding

5.1M

Costof Debt

5.86

Tax Rate

After Tax Cost Of Debt

2.78

Risk Free Rate

Market Risk Premium

Cost Of Equity

Total Debt

340.3M

Total Equity

584.62M

Total Capital

924.91M

Debt Weighting

36.79

Equity Weighting

63.21

Wacc

10.74

Build Up Free Cash Flow

Year

2020

2021

2022

2023

2024

2025

2026

2027

2028

2029

Revenue

273.42M

331.53M

219.29M

247.65M

479.95M

592.89M

732.42M

904.78M

1.12B

1.38B

Ebitda

-5.12M

183.45M

-393.96M

-14.58M

148.65M

-25.44M

-31.43M

-38.82M

-47.96M

-59.24M

Ebit

-5.35M

175.69M

-407.16M

-32.17M

129.68M

-41.43M

-51.18M

-63.22M

-78.1M

-96.48M

Tax Rate

52.46

52.46

52.46

52.46

52.46

52.46

52.46

52.46

52.46

52.46

Ebiat

-3.9M

137.44M

-419.86M

-30.38M

61.66M

-32.56M

-40.23M

-49.69M

-61.39M

-75.83M

Depreciation

236.55k

7.76M

13.2M

17.59M

18.97M

23.12M

28.57M

35.29M

43.59M

53.85M

Receivables

108.14M

114.76M

58.32M

62.78M

236.05M

207.86M

256.77M

317.19M

391.84M

484.05M

Inventories

1.73M

2.81M

3.53M

3.39M

2.85M

5.99M

7.4M

9.15M

11.3M

13.96M

Payable

8.63M

17.65M

23.93M

25.28M

13.96M

38.55M

47.62M

58.83M

72.67M

89.78M

Cap Ex

-61.19M

-36.93M

-14.63M

-9.5M

-2.3M

-52.77M

-65.19M

-80.54M

-99.49M

-122.9M

Ufcf

-166.09M

109.59M

-359.29M

-25.25M

-105.73M

-12.57M

-118.11M

-145.9M

-180.23M

-222.65M

Wacc

10.74

10.74

10.74

10.74

10.74

Pv Ufcf

-11.35M

-96.31M

-107.43M

-119.84M

-133.69M

Sum Pv Ufcf

-468.61M

Terminal Value

Growth In Perpetuity Method

Long Term Growth Rate

Wacc

10.74

Free Cash Flow T1

-227.1M

Terminal Value

-2.6B

Present Terminal Value

-1.56B

Intrinsic Value

Enterprise Value

-2.03B

Net Debt

296.72M

Equity Value

-2.33B

Diluted Shares Outstanding

5.1M

Equity Value Per Share

-455.93

Projected DCF

-455.93 1.251%

DCF Levered

Download Excel

FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedin
2017-2025 © Financial Modeling Prep